Obesity paradox in patients on maintenance dialysis

Contributions to Nephrology

Volumn 151, Issue , 2006, Pages 57-69

  Kalantar Zadeh, Kamyar ^a   Kopple, Joel D ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; HUMAN; MORTALITY; OBESITY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SURVIVAL;

HUMANS; KIDNEY FAILURE, CHRONIC; OBESITY; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 33748059224     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095319     Document Type: Review

References (79)

1. Goodkin DA, Mapes DL, Held PJ: The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 2001;14:157-159.
2. United States Renal Data System: Excerpts from the USRDS 2004 Annual Data Report. Am J Kid Dis 2005;45(suppl 1):S1-S280.
3. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
4. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-248.
5. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
6. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
7. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
8. Kopple JD: The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr 2005;81:1257-1266.
9. Kalantar-Zadeh K, Kopple JD, Kilpatnck RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005;46:489-500.
10. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999;56:1136-1148.
11. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 2005;45:811-817.
12. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H: Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 2001;38:S4-S7.
13. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD: A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004;15:442-453.
14. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
15. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.
16. Kalantar-Zadeh K: Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 2005;15:142-147.
17. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-211.
18. Lev-Ran A: Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 2001;17:347-362.
19. Birkner R: Plan and Initial Program of the Health Examination Survey. Vital Health Stat 1 1965;125:1-43.
20. Miller HW: Plan and operation of the health and nutrition examination survey. United States - 1971-1973. Vital Health Stat 1 1973;1:1-46.
21. McDowell A, Engel A, Massey JT, Maurer K: Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. Vital Health Stat 1 1981;1:1-144.
22. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
23. Byers T: Body weight and mortality. N Engl J Med 1995;333:723-724.
24. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 1995;333:677-685.
25. Lew EA, Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-576.
26. Hsu C-y, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-28.
27. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.
28. Kalantar-Zadeh K, Kopple JD: Body mass index and risk for end-stage renal disease. Ann Intern Med, 2006;144:21-28.
29. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
30. United States Renal Data System: US Department of Public Health and Human Services. Public Health Service. Bethesda, National Institutes of Health, 2003.
31. Kopple JD: Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 1997;43:246-250.
32. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, Stringer WW: A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int 2005;9:314-324.
33. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane Collaborative Study. Nephron 1982;31:103-110.
34. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998;31:997-1006.
35. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999;55:1560-1567.
36. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000;35:80-88.
37. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13:1061-1066.
38. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001;16:2386-2394.
39. Glanton CW, Hypolite IO, Hshieh PB, Agodoa LY, Yuan CM, Abbott KC: Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol 2003;13:136-143.
40. Johansen KL, Young B, Kaysen GA, Chertow GM: Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004;80:324-332.
41. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002;62:1891-1897.
42. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14:2366-2372.
43. Kalantar-Zadeh K, Abbott KC, Salahudeen AK: Reverse epidemiology of obesity in dialysis patients: fat or muscle? Am J Clin Nutr 2005;82:910-911.
44. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006;83:202-210.
45. Canada-USA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
46. Hakim RM, Lowrie E: Obesity and mortality in ESRD: is it good to be fat? Kidney Int 1999;55:1580-1581.
47. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: How much peritoneal dialysis is necessary for maintaining a good nutritional status? Kidney Int 1996;56:(Suppl)S56-S61.
48. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM: Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000;20:715-721.
49. Chung SH, Lindholm B, Lee HB: Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int 2000;20:19-26.
50. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64:1838-1844.
51. McDonald SP, Collins JF, Johnson DW: Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003;14:2894-2901.
52. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004;65:597-605.
53. Aslam N, Bernardini J, Fried L, Piraino B: Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 2002;22:191-196.
54. Stack AG, Murthy BV, Molony DA: Survival differences between peritoneal dialysis and hemodialysis among 'large' ESRD patients in the United States. Kidney Int 2004;65:2398-2408.
55. Ramkumar N, Pappas LM, Beddhu S: Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int 2005;25:461-469.
56. Foley RN: Body mass index and survival in peritoneal dialysis patients. Perit Dial Int 2005;25:435-437.
57. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
58. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL: The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:1-7.
59. Yeh S, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, Schuster MW: Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 2000;4:246-251.
60. Chlebowski RT, Grosvenor M, Lillington L, Sayre J, Beall G: Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc 1995;95:428-432; quiz 433-425.
61. Wilson DO, Rogers RM, Wright EC, Anthonisen NR: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989;139:1435-1438.
62. Escalante A, Haas RW, del Rincon I: Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165:1624-1629.
63. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY: Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 2005;23:57-63.
64. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC: Epidemiology of dialysis patients and heart failure patients; special review article for the 25th anniversary of the Seminars in Nephrology. Semin Nephrol 2006;26:118-133.
65. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439-1444.
66. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH: The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789-795.
67. Schrier RW, Abraham WT: Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585.
68. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
69. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L: Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004;65:274-281.
70. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW: Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277:E971-E975.
71. McClellan WM, Chertow GM: Beyond framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol 2005;16:1539-1541.
72. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-1842.
73. Rauchhaus M, Coats AJ, Anker SD: The endotoxin-lipoprotein hypothesis. Lancet 2000;356:930-933.
74. Jandacek RJ, Anderson N, Liu M, Zheng S, Yang Q, Tso P: Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol 2005;288:G292-G299.
75. Imbeault P, Tremblay A, Simoneau JA, Joanisse DR: Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. Am J Physiol Endocrinol Metab 2002;282:E574-E579.
76. Macleod J, Davey Smith G: Psychosocial factors and public health: a suitable case for treatment? J Epidemiol Community Health 2003;57:565-570.
77. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-999.
78. Kalantar-Zadeh K, Balakrishnan VS: The kidney disease wasting: inflammation, oxidative stress and diet-gene interaction. Hemodial Int 2006, in press.
79. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ: Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004;291:451-459.